China SXT Pharmaceuticals (SXTC) Debt Ratio (2019 - 2025)
Historic Debt Ratio for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to 0.0.
- China SXT Pharmaceuticals' Debt Ratio fell 9879.34% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 9879.34%. This contributed to the annual value of 0.0 for FY2025, which is 8162.16% down from last year.
- According to the latest figures from Q3 2025, China SXT Pharmaceuticals' Debt Ratio is 0.0, which was down 9879.34% from 0.0 recorded in Q1 2025.
- Over the past 5 years, China SXT Pharmaceuticals' Debt Ratio peaked at 0.35 during Q1 2021, and registered a low of 0.0 during Q1 2022.
- Moreover, its 5-year median value for Debt Ratio was 0.04 (2022), whereas its average is 0.1.
- Its Debt Ratio has fluctuated over the past 5 years, first surged by 358335.06% in 2021, then plummeted by 9990.34% in 2022.
- China SXT Pharmaceuticals' Debt Ratio (Quarter) stood at 0.09 in 2021, then crashed by 41.79% to 0.05 in 2022, then skyrocketed by 228.13% to 0.18 in 2023, then soared by 36.74% to 0.24 in 2024, then plummeted by 98.79% to 0.0 in 2025.
- Its Debt Ratio was 0.0 in Q3 2025, compared to 0.0 in Q1 2025 and 0.24 in Q3 2024.